Longevity compound screening
Screen candidates against defined aging-associated readouts.
APPLICATIONS
The initial use case is measuring aging-associated biology and screening compounds against defined readouts.
Screen candidates against defined aging-associated readouts.
Investigate whether candidate interventions engage intended biological pathways.
Generate complementary evidence for future therapeutic development.